|
| Status |
Public on Apr 12, 2012 |
| Title |
002-005 |
| Sample type |
RNA |
| |
|
| Source name |
ovarian tissue biopsy
|
| Organism |
Homo sapiens |
| Characteristics |
batch: 1
percent.present: 55.56
scale.factor: 0.38
gapdh.3.5: 1.19
actin.3.5: 2.43
average.correlation: 0.91
qc.flag: PASS
patient identifier: 002-005
indicator of clinical response (cr=1/pr=2/sd=3): 3
overall survival (years): 0.604805749
status for overall survival (1=death, 0=censored): 1
progression free survival (years): 0.604805749
status for progression free survival (1=death, 0=censored): 1
objective response (1 = cr or pr, 0= sd): 0
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen RNeasy Mini Kit
|
| Label |
biotin
|
| Label protocol |
Prepared samples using the Affymetrix GeneChip ENZO one cycle labeling kit
|
| |
|
| Hybridization protocol |
Hybridization of samples to Affymetrix GeneChip arrays was performed according to Affymetrix manual instructions
|
| Scan protocol |
Scanning of Affymetrix GeneChip arrays was performed according to the Affymerix manual instructions
|
| Description |
002-005
|
| Data processing |
Data is RMA normalized using R/Bioconductor
|
| |
|
| Submission date |
Apr 11, 2012 |
| Last update date |
Apr 25, 2012 |
| Contact name |
Miao yu |
| E-mail(s) |
miao.yu@duke.edu
|
| Organization name |
Duke
|
| Street address |
Laselle drive
|
| City |
durham |
| ZIP/Postal code |
27710 |
| Country |
USA |
| |
|
| Platform ID |
GPL571 |
| Series (1) |
| GSE37180 |
Gene expression profiles of ovarian tumor biopsies from Phase I dasatinib trial |
|
